The reporting of Traits, Treatment and Germplasm is a difficult and cumbersome process for manufacturers, distributors and retailers. Each Germplasm manufacturer (defined as Company who has the rights to specific germplasm) has different ways that they want the reporting and the definition of terms varies between manufacturers. Manufacturers reporting to other manufacturers have not always been consistent or timely.  In addition, distributors and retailers need to report one single sale to multiple manufacturers.  Having the technology to complete the multiple reporting has been a barrier.

By standardizing the format, process and mechanism of how trait, treatment and germplasm is reported to manufacturers will require less labor intensive processes and a more consistent and timely reporting of the information for both manufacturers and distributors/retailers.

Updates: 

The GTTR project board has determined at this point, they will delay the Phase 1 portion of this project until July/August of 2010.  A commitment letter will be sent out in mid May with an open Forum at the CCP meeting in Indianapolis in June.  Targeted date for the commitment letter deadline is 7/15/10 and a targeted kick-off meeting set for late July or early August.